• 2023
  Llach Pou M, Thiberge C, Van der Zwan M, Devi Govindan A, Pons S, Maskos U, Cloëz-Tayarani I, Developmental Changes of Human Neural Progenitor Cells Grafted into the Ventricular System and Prefrontal Cortex of Mouse Brain in Utero., Cells 2023 Mar; 12(7): .
• 2020
  Vitrac A, Pons S, Balkota M, Lemière N, Raïs C, Bourgeois JP, Maskos U, Bourgeron T, Cloëz-Tayarani I, , A chimeric mouse model to study human iPSC-derived neurons: the case of a truncating SHANK3 mutation., Sci Rep 2020 08; 10(1): 13315.
• 2019
  Gouder L, Vitrac A, Goubran-Botros H, Danckaert A, Tinevez JY, André-Leroux G, Atanasova E, Lemière N, Biton A, Leblond CS, Poulet A, Boland A, Deleuze JF, Benchoua A, Delorme R, Bourgeron T, Cloëz-Tayarani I, , Altered spinogenesis in iPSC-derived cortical neurons from patients with autism carrying de novo SHANK3 mutations., Sci Rep 2019 01; 9(1): 94.
• 2018
  Vitrac A, Cloëz-Tayarani I, Induced pluripotent stem cells as a tool to study brain circuits in autism-related disorders, Stem Cell Res Ther 2018 Aug;9(1):226.
• 2016
  Mercati O, Huguet G, Danckaert A, André-Leroux G, Maruani A, Bellinzoni M, Rolland T, Gouder L, Mathieu A, Buratti J, Amsellem F, Benabou M, Van-Gils J, Beggiato A, Konyukh M, Bourgeois JP, Gazzellone MJ, Yuen RK, Walker S, Delépine M, Boland A, Régnault B, Francois M, Van Den Abbeele T, Mosca-Boidron AL, Faivre L, Shimoda Y, Watanabe K, Bonneau D, Rastam M, Leboyer M, Scherer SW, Gillberg C, Delorme R, Cloëz-Tayarani I, Bourgeron T, CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders, Mol. Psychiatry 2017 04;22(4):625-633.
• 2013
  Maouche K, Medjber K, Zahm JM, Delavoie F, Terryn C, Coraux C, Pons S, Cloëz-Tayarani I, Maskos U, Birembaut P, Tournier JM, , Contribution of α7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure., Proc Natl Acad Sci U S A 2013 Mar; 110(10): 4099-104.
• 2011
  Besson M, David V, Baudonnat M, Cazala P, Guilloux JP, Reperant C, Cloez-Tayarani I, Changeux JP, Gardier AM, Granon S, Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice, Psychopharmacology (Berl.) 2012 Mar;220(1):1-14.
• 2011
  Lykhmus O, Koval L, Skok M, Zouridakis M, Zisimopoulou P, Tzartos S, Tsetlin V, Granon S, Changeux JP, Komisarenko S, Cloëz-Tayarani I, Antibodies against extracellular domains of α4 and α7 subunits alter the levels of nicotinic receptors in the mouse brain and affect memory: possible relevance to Alzheimer’s pathology, J. Alzheimers Dis. 2011;24(4):693-704.
• 2009
  Lykhmus O, Koval L, Pavlovych S, Zouridakis M, Zisimopoulou P, Tzartos S, Tsetlin V, Volpina O, Cloëz-Tayarani I, Komisarenko S, Skok M, Functional effects of antibodies against non-neuronal nicotinic acetylcholine receptors, Immunol. Lett. 2010 Jan;128(1):68-73.
• 2009
  Maouche K, Polette M, Jolly T, Medjber K, Cloëz-Tayarani I, Changeux JP, Burlet H, Terryn C, Coraux C, Zahm JM, Birembaut P, Tournier JM, {alpha}7 nicotinic acetylcholine receptor regulates airway epithelium differentiation by controlling basal cell proliferation, Am. J. Pathol. 2009 Nov;175(5):1868-82.
• 2008
  Grailhe R, Cardona A, Even N, Seif I, Changeux JP, Cloëz-Tayarani I, Regional changes in the cholinergic system in mice lacking monoamine oxidase A, Brain Res. Bull. 2009 Mar;78(6):283-9.
• 2008
  Wiklund A, Granon S, Cloëz-Tayarani I, Faure P, le Sourd AM, Sundman E, Changeux JP, Eriksson LI, Sevoflurane anesthesia alters exploratory and anxiety-like behavior in mice lacking the beta2 nicotinic acetylcholine receptor subunit, Anesthesiology 2008 Nov;109(5):790-8.
• 2008
  Even N, Cardona A, Soudant M, Corringer PJ, Changeux JP, Cloëz-Tayarani I, Regional differential effects of chronic nicotine on brain alpha 4-containing and alpha 6-containing receptors, Neuroreport 2008 Oct;19(15):1545-50.
• 2007
  Besson M, Granon S, Mameli-Engvall M, Cloëz-Tayarani I, Maubourguet N, Cormier A, Cazala P, David V, Changeux JP, Faure P, Long-term effects of chronic nicotine exposure on brain nicotinic receptors, Proc. Natl. Acad. Sci. U.S.A. 2007 May;104(19):8155-60.
• 2006
  Cloëz-Tayarani I, Changeux JP, Nicotine and serotonin in immune regulation and inflammatory processes: a perspective, J. Leukoc. Biol. 2007 Mar;81(3):599-606.
• 2006
  Molles BE, Maskos U, Pons S, Besson M, Guiard P, Guilloux JP, Evrard A, Cormier A, Mameli-Engvall M, Cloëz-Tayarani I, Nakatani H, Dufour N, Bemelmans AP, Mallet J, Cazala P, Gardier AM, David V, Faure P, Granon S, Changeux JP, , Targeted in vivo expression of nicotinic acetylcholine receptors in mouse brain using lentiviral expression vectors., J. Mol. Neurosci. 2006 ; 30(1-2): 105-6.
• 2006
  Tournier JM, Maouche K, Coraux C, Zahm JM, Cloëz-Tayarani I, Nawrocki-Raby B, Bonnomet A, Burlet H, Lebargy F, Polette M, Birembaut P, alpha3alpha5beta2-Nicotinic acetylcholine receptor contributes to the wound repair of the respiratory epithelium by modulating intracellular calcium in migrating cells, Am. J. Pathol. 2006 Jan;168(1):55-68.
• 2005
  Mrsic-Flogel TD, Hofer SB, Creutzfeldt C, Cloëz-Tayarani I, Changeux JP, Bonhoeffer T, Hübener M, Altered map of visual space in the superior colliculus of mice lacking early retinal waves, J. Neurosci. 2005 Jul;25(29):6921-8.
• 2005
  Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP, Evrard A, Cazala P, Cormier A, Mameli-Engvall M, Dufour N, Cloëz-Tayarani I, Bemelmans AP, Mallet J, Gardier AM, David V, Faure P, Granon S, Changeux JP, , Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors., Nature 2005 Jul; 436(7047): 103-7.
• 2004
  Cloëz-Tayarani I, Kayyali US, Fanburg BL, Cavaillon JM, 5-HT activates ERK MAP kinase in cultured-human peripheral blood mononuclear cells via 5-HT1A receptors, Life Sci. 2004 Dec;76(4):429-43.
• 2003
  Cloëz-Tayarani I, Petit-Bertron AF, Venters HD, Cavaillon JM, Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors, Int. Immunol. 2003 Feb;15(2):233-40.
• 2001
  Cavaillon JM, Adib-Conquy M, Cloëz-Tayarani I, Fitting C, Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review, J. Endotoxin Res. 2001;7(2):85-93.
• 1999
  Sarhan H, Cloëz-Tayarani I, Massot O, Fillion MP, Fillion G, 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes, Naunyn Schmiedebergs Arch. Pharmacol. 1999 Jan;359(1):40-7.
• 1998
  Massot O, Rousselle JC, Grimaldi B, Cloëz-Tayarani I, Fillion MP, Plantefol M, Bonnin A, Prudhomme N, Fillion G, Molecular, cellular and physiological characteristics of 5-HT-moduline, a novel endogenous modulator of 5-HT1B receptor subtype, Ann. N. Y. Acad. Sci. 1998 Dec;861:174-82.
• 1998
  Cloëz-Tayarani I, Cardona A, Sarhan H, Rousselle JC, Massot O, Edelman L, Fillion G, Mapping of 5-HT-moduline binding sites in guinea-pig brain by film and digital autoradiography, Brain Res. 1998 Jul;798(1-2):311-5.
• 1997
  Cloëz-Tayarani I, Cardona A, Rousselle JC, Massot O, Edelman L, Fillion G, Autoradiographic characterization of [3H]-5-HT-moduline binding sites in rodent brain and their relationship to 5-HT1B receptors, Proc. Natl. Acad. Sci. U.S.A. 1997 Sep;94(18):9899-904.
• 1997
  Cloëz-Tayarani I, Fillion G, The in situ hybridization and immunocytochemistry techniques for characterization of cells expressing specific mRNAs in paraffin-embedded brains, Brain Res. Brain Res. Protoc. 1997 May;1(2):195-202.
• 1996
  Massot O, Rousselle JC, Fillion MP, Grimaldi B, Cloëz-Tayarani I, Fugelli A, Prudhomme N, Seguin L, Rousseau B, Plantefol M, Hen R, Fillion G, 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors, Mol. Pharmacol. 1996 Oct;50(4):752-62.
• 1996
  Cloëz-Tayarani I, Wusher N, Huerre M, Fillion G, Cellular localization of 5-HT1B receptor mRNA in the rat olfactory tubercle: do GABAergic neurons express the 5-HT1B gene?, Brain Res. Mol. Brain Res. 1996 Mar;36(2):337-42.
• 1995
  Bolanos-Jimenez F, Manhaes de Castro RM, Seguin L, Cloez-Tayarani I, Monneret V, Drieu K, Fillion G, Effects of stress on the functional properties of pre- and postsynaptic 5-HT1B receptors in the rat brain, Eur. J. Pharmacol. 1995 Dec;294(2-3):531-40.
• 1995
  Grimaldi B, Cloez-Tayarani I, Fillion MP, Mazie JC, Hen R, Fillion G, Production and characterization of an antibody directed against the mouse 5HT1B receptor, Neurosci. Res. 1995 Dec;24(1):97-101.
• 1993
  Cloëz-Tayarani I, Fillion G, [Fundamental aspects of molecular biology. The multigene family of 5-HT1 receptors], Encephale 1993 May-Jun;19(3):215-9.
• 1993
  Simon-Chazottes D, Cloez-Tayarani I, Fillion MP, Guénet JL, Fillion G, The serotonin 5-HT1B receptor subtype (Htr1b) gene maps to mouse chromosome 9, Mamm. Genome 1993;4(7):397-8.
• 1992
  Weydert A, Cloez-Tayarani I, Fillion MP, Simon-Chazottes D, Guenet JL, Fillion G, Molecular cloning of two partial serotonin 5-HT1D receptor sequences in mouse and one in guinea pig, C. R. Acad. Sci. III, Sci. Vie 1992;314(10):429-35.
• 1992
  Cloëz-Tayarani I, Harel-Dupas C, Fillion G, Inhibition of [3H] gamma-aminobutyric acid release from guinea-pig hippocampal synaptosomes by serotonergic agents, Fundam Clin Pharmacol 1992;6(8-9):333-41.
• 1991
  Harel-Dupas C, Cloëz I, Fillion G, , Antagonism by antidepressant drugs of the inhibitory effect of trifluoromethylphenylpiperazine (TFMPP) on [3H]acetylcholine release in rat or guinea-pig hippocampal synaptosomes., Eur Neuropsychopharmacol 1991 May; 1(2): 157-64.
• 1991
  Harel-Dupas C, Cloëz I, Fillion G, , The inhibitory effect of trifluoromethylphenylpiperazine on [3H]acetylcholine release in guinea pig hippocampal synaptosomes is mediated by a 5-hydroxytryptamine1 receptor distinct from 1A, 1B, and 1C subtypes., J Neurochem 1991 Jan; 56(1): 221-7.
• 1991
  Fillion G, Barone P, Cloëz I, Fillion MP, Harel C, Massot O, Rousselle JC, Zifa E, , A cerebral endogenous factor regulates the activity of the serotonergic receptors modulating the neuronal release of acetylcholine., Adv Exp Med Biol 1991 ; 287(): 165-76.
• 1989
  Tayarani I, Cloëz I, Lefauconnier JM, Bourre JM, , Sodium-dependent high-affinity uptake of taurine by isolated rat brain capillaries., Biochim Biophys Acta 1989 Oct; 985(2): 168-72.
• 1989
  Tayarani I, Cloëz I, Clément M, Bourre JM, , Antioxidant enzymes and related trace elements in aging brain capillaries and choroid plexus., J Neurochem 1989 Sep; 53(3): 817-24.
• 1989
  Cloëz I, Tayarani I, Morel F, Bourre JM, , Alterations in protective enzymes against peroxidation in the central and peripheral nervous system of control and dysmyelinating mutant mice., J Neurochem 1989 May; 52(5): 1353-8.
• 1987
  Cloëz I, Bourre JM, , Copper, manganese and zinc in the developing brain of control and quaking mice., Neurosci Lett 1987 Dec; 83(1-2): 118-22.
• 1987
  Cloëz I, Dumont O, Piciotti M, Bourre JM, , Alterations of lipid synthesis in the normal and dysmyelinating trembler mouse sciatic nerve by heavy metals (Hg, Pb, Mn, Cu, Ni)., Toxicology 1987 Oct; 46(1): 65-71.
• 1987
  Bourre JM, Cloez I, Galliot M, Buisine A, Dumont O, Piciotti M, Prouillet F, Bourdon R, , Occurrence of manganese, copper and zinc in myelin. Alterations in the peripheral nervous system of dysmyelinating trembler mutant are at variance with brain mutants (quaking and shiverer)., Neurochem Int 1987 ; 10(3): 281-6.